Discontinued — last reported Q4 '25
Veradermics Short-Term Investments increased by 85.2% to $222.39M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate strong liquidity and significant 'dry powder' for acquisitions or R&D, while lower levels might suggest cash is being deployed into long-term projects or shareholder returns.
Highly liquid assets and marketable securities that are expected to be converted into cash within one year. For technolo...
Commonly compared against other cash-rich technology peers to assess capital preservation strategies and short-term solvency.
short_term_investments| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $120.10M | $222.39M |
| QoQ Change | — | +85.2% |